ACCESSION: MSBNK-SMB_Measured-HSA033P0156003
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.03.25 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.03.25, Curated 2025.03.25)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'C15neg_359': {'bp': 2027.0, 'sum': 7018.0}, 'D102neg_361': {'bp': 1756.0, 'sum': 5881.0}, 'C11neg_362': {'bp': 1421.0, 'sum': 7093.0}, 'C7neg_347': {'bp': 1187.0, 'sum': 5343.0}, 'D87neg_348': {'bp': 1186.0, 'sum': 6221.0}, 'C2neg_358': {'bp': 935.0, 'sum': 3639.0}, 'D171neg_350': {'bp': 908.0, 'sum': 4032.0}, 'C9neg_355': {'bp': 898.0, 'sum': 4553.0}, 'C18neg_350': {'bp': 897.0, 'sum': 3863.0}, 'C12neg_346': {'bp': 731.0, 'sum': 3552.0}, 'C4neg_353': {'bp': 694.0, 'sum': 3669.0}, 'C12neg_359': {'bp': 678.0, 'sum': 2669.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 156.066676
COMMENT: PRECURSOR_M/Z_STDEV 0.000693
COMMENT: PRECURSOR_IN_MS1 mz 156.066794; int 505.433; delta(ppm) 0.701926
COMMENT: PROPOSED_CHARGE_STATE -1; mz 157.068826; int 26.776; cor 0.853
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+Cl; M+TFA-H; mz 234.078868; int 2.928; cor 0.601
COMMENT: PROPOSED_ION_FORM M+Hac-H; M+FA-H; mz 142.051424; int 513.853; cor 0.706
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 18.520; C6H12N3P; [M-H]1; delta(ppm) -18.519936
COMMENT: PROPOSED_MF SevenGoldenRules 0.509; C7H11NO3; [M-H]1; delta(ppm) 0.509314
COMMENT: PROPOSED_MF SevenGoldenRules 0.845; C5H7NO; [M+Hac-H]1; delta(ppm) 0.844901
COMMENT: PROPOSED_MF MS-FINDER 3.060; C7H11NO3; [M-H]-; delta(ppm) 0.513932
COMMENT: PROPOSED_MF MS-FINDER 2.842; C5H7NO; [M+Hac-H]-; delta(ppm) 642156.310215
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.238; C4H13N2O2; [M+Cl]-; delta(ppm) -133285.906775
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.053; C5H7NO; [M+C2H4O2-H]-; delta(ppm) 1294619.743484
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.053; C7H11NO3; [M-H]-; delta(ppm) 0.513932
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.506; C2H11N5O; [M+Cl]-; delta(ppm) -133279.444106
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.914; C3H5N4; [M+C2H4O2-H]-; delta(ppm) 857765.263475
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.914; C5H9N4O2; [M-H]-; delta(ppm) 9.117154
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.367; C5H11BN2OS; [M-H]-; delta(ppm) 68569.886539
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.223; BH3N6; [M+C2H4O2-H]-; delta(ppm) 380855.644542
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.223; C2H7BN6O2; [M-H]-; delta(ppm) 68541.795902
COMMENT: PROPOSED_MF SIRIUS6_Sirius -9.634; BH5N9O; [M-H]-; delta(ppm) 68551.618899
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.906; C5H7NO; [M+C2H4O2-H]-; delta(ppm) 1294619.743484
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.874; C7H11NO3; [M-H]-; delta(ppm) 0.513932
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.859; C4H13N2O2; [M+Cl]-; delta(ppm) -133285.906775
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.141; C2H11N5O; [M+Cl]-; delta(ppm) -133279.444106
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.108; C5H9N4O2; [M-H]-; delta(ppm) 9.117154
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.090; C3H5N4; [M+C2H4O2-H]-; delta(ppm) 857765.263475
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.011; C5H11BN2OS; [M-H]-; delta(ppm) 68569.886539
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.007; C2H7BN6O2; [M-H]-; delta(ppm) 68541.795902
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.004; BH3N6; [M+C2H4O2-H]-; delta(ppm) 380855.644542
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; UKQLYCSMIVXPDB-MLHKIVSYNA-N; [M-H]-; COC(=O)[C@H]1CCCC(=O)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; FXXRPTKTLVHPAR-UHFFFAOYSA-N; [M-H]-; C1N2CN3CN1CP(C2)C3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; XFMMSQQRBYPHPZ-UHFFFAOYSA-N; [M-H]-; O=C(OC)C(C(=O)C)C(=N)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; VBBWEKADEDMWDH-UHFFFAOYSA-N; [M-H]-; O=C1C=CC(O)CC(O)CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MGICTTHNDAIMFI-UHFFFAOYSA-N; [M-H]-; O=C(OC)CNC(=O)CC=C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.727; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M-H]-; 3-Methylcrotonylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.727; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M-H]-; Paramethadione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.675; GNMSLDIYJOSUSW-LURJTMIESA-N; [M-H]-; N-Acetylproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.675; WRUSVQOKJIDBLP-HWKANZROSA-N; [M-H]-; Tiglylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.570; UEGDICIJUUEIOL-FSPLSTOPSA-N; [M-H]-; 2-Hydroxyethylclavam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.466; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M-H]-; methyl 1-methyl-5-oxo-L-prolinate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.466; PNOKUGWGMLEAPE-LMPMJJBRNA-N; [M-H]-; furanomycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.466; ABNUGWRZSYVEEW-APVHJGEINA-N; [M-H]-; UNPD20878
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; PDEQNWFUJRROAD-IFSCUNPJNA-N; [M-H]-; UNPD109941
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; PEAQTUDKZGSVCV-DWFKHXNSNA-N; [M-H]-; UNPD165417
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; QYJOOVQLTTVTJY-MLHKIVSYNA-N; [M-H]-; UNPD56624
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; UKQLYCSMIVXPDB-MLHKIVSYNA-N; [M-H]-; UNPD93618
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; VLIHXBQWXDIQTE-MZQZIECVNA-N; [M-H]-; UNPD140628
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; VSVIYBLRPXAQBF-SNAWJCMRSA-N; [M-H]-; UNPD149056
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; ZESDLVJGIBGADW-MZQZIECVNA-N; [M-H]-; UNPD146866
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.414; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M-H]-; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M-H]-; Ethadione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M-H]-; methyl 2-oxopyrrolidin-1-acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; FQOWJGGXNSRNJS-YFKPBYRVSA-N; [M-H]-; (2S)-2-(2-methylprop-2-enoylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; VQYNVVZGKXZWFV-UHFFFAOYSA-N; [M-H]-; 2-imino-5-methyl-3-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; CESXXYZXSIXCFU-UHFFFAOYSA-N; [M-H]-; 1-amino-4-oxocyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; FXIQOWGSQOLZSR-UHFFFAOYSA-N; [M-H]-; N,N-dimethyl-5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; LZHSHKSQRPIMMV-UHFFFAOYSA-N; [M-H]-; methyl 3-acetamidobut-2-enoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; MGICTTHNDAIMFI-UHFFFAOYSA-N; [M-H]-; methyl 2-(but-3-enamido)acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; VBBWEKADEDMWDH-UHFFFAOYSA-N; [M-H]-; CNP0446389
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.362; XFMMSQQRBYPHPZ-UHFFFAOYSA-N; [M-H]-; methyl 2-acetyl-3-iminobutanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.352; PBCLOVRWBLGJQA-UHFFFAOYNA-N; [M+Hac-H]-; 1-Cyano-2-hydroxy-3-butene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.248; NSAUQTCATRWAJC-UHFFFAOYSA-N; [M+Hac-H]-; 2,5-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.248; PSOZJOZKEVZLKZ-UHFFFAOYSA-N; [M+Hac-H]-; 2,4-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.248; YVORRVFKHZLJGZ-UHFFFAOYSA-N; [M+Hac-H]-; 4,5-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.196; GZTZLYWUGFZVSM-UHFFFAOYSA-N; [M+Hac-H]-; UNPD103572
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.196; OXMKNUCRSLQWMI-UHFFFAOYSA-N; [M+Hac-H]-; UNPD226481
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.196; OXRRHYRRQWIHIV-UHFFFAOYSA-N; [M+Hac-H]-; UNPD63934
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.196; SEYPSMUGVMMWTC-UHFFFAOYSA-N; [M+Hac-H]-; UNPD190150
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.196; XJITTZAUZHVBLF-UHFFFAOYSA-N; [M+Hac-H]-; UNPD10382
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; AMQCWPDDXYOEER-UHFFFAOYNA-N; [M+Hac-H]-; 3-cyano-2-butanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; DDRPCXLAQZKBJP-UHFFFAOYSA-N; [M+Hac-H]-; furfurylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; AKXFVHOXDAJSMM-UHFFFAOYSA-N; [M+Hac-H]-; 2-hydroxypent-3-enenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; FICAQKBMCKEFDI-UHFFFAOYSA-N; [M+Hac-H]-; 3,5-dimethyl-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; JFVBCXHSPKJLRP-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxopentanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; WJTPWAHVZOSBBG-UHFFFAOYSA-N; [M+Hac-H]-; 2-hydroxypent-2-enenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.144; FYXXJXKLTCPPHW-UHFFFAOYSA-N; [M+Hac-H]-; 2-methoxy-1H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MGICTTHNDAIMFI-UHFFFAOYSA-N; [M-H]-; methyl 2-(but-3-enamido)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PBCLOVRWBLGJQA-UHFFFAOYNA-N; [M+Hac-H]-; 1-Cyano-2-hydroxy-3-butene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; OXRRHYRRQWIHIV-UHFFFAOYSA-N; [M+Hac-H]-; UNPD63934
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.809; PNOKUGWGMLEAPE-LMPMJJBRNA-N; [M-H]-; furanomycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.801; WRUSVQOKJIDBLP-HWKANZROSA-N; [M-H]-; Tiglylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.714; PEAQTUDKZGSVCV-DWFKHXNSNA-N; [M-H]-; UNPD165417
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.714; QYJOOVQLTTVTJY-MLHKIVSYNA-N; [M-H]-; UNPD56624
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.668; FICAQKBMCKEFDI-UHFFFAOYSA-N; [M+Hac-H]-; 3,5-dimethyl-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.666; YVORRVFKHZLJGZ-UHFFFAOYSA-N; [M+Hac-H]-; 4,5-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.666; PSOZJOZKEVZLKZ-UHFFFAOYSA-N; [M+Hac-H]-; 2,4-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.657; GNMSLDIYJOSUSW-LURJTMIESA-N; [M-H]-; N-Acetylproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.657; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M-H]-; methyl 2-oxopyrrolidin-1-acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.649; PDEQNWFUJRROAD-IFSCUNPJNA-N; [M-H]-; UNPD109941
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.643; FQOWJGGXNSRNJS-YFKPBYRVSA-N; [M-H]-; (2S)-2-(2-methylprop-2-enoylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M-H]-; methyl 1-methyl-5-oxo-L-prolinate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; ABNUGWRZSYVEEW-APVHJGEINA-N; [M-H]-; UNPD20878
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; UKQLYCSMIVXPDB-MLHKIVSYNA-N; [M-H]-; UNPD93618
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M-H]-; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; CESXXYZXSIXCFU-UHFFFAOYSA-N; [M-H]-; 1-amino-4-oxocyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.638; FXIQOWGSQOLZSR-UHFFFAOYSA-N; [M-H]-; N,N-dimethyl-5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.635; VBBWEKADEDMWDH-UHFFFAOYSA-N; [M-H]-; CNP0446389
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.627; OXMKNUCRSLQWMI-UHFFFAOYSA-N; [M+Hac-H]-; UNPD226481
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.615; FYXXJXKLTCPPHW-UHFFFAOYSA-N; [M+Hac-H]-; 2-methoxy-1H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.589; NSAUQTCATRWAJC-UHFFFAOYSA-N; [M+Hac-H]-; 2,5-Dimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.587; DDRPCXLAQZKBJP-UHFFFAOYSA-N; [M+Hac-H]-; furfurylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.551; UEGDICIJUUEIOL-FSPLSTOPSA-N; [M-H]-; 2-Hydroxyethylclavam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.473; ZESDLVJGIBGADW-MZQZIECVNA-N; [M-H]-; UNPD146866
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.455; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M-H]-; Ethadione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.445; AKXFVHOXDAJSMM-UHFFFAOYSA-N; [M+Hac-H]-; 2-hydroxypent-3-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.439; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M-H]-; 3-Methylcrotonylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.434; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M-H]-; Paramethadione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.374; VLIHXBQWXDIQTE-MZQZIECVNA-N; [M-H]-; UNPD140628
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; VQYNVVZGKXZWFV-UHFFFAOYSA-N; [M-H]-; 2-imino-5-methyl-3-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; LZHSHKSQRPIMMV-UHFFFAOYSA-N; [M-H]-; methyl 3-acetamidobut-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; XFMMSQQRBYPHPZ-UHFFFAOYSA-N; [M-H]-; methyl 2-acetyl-3-iminobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.136; AMQCWPDDXYOEER-UHFFFAOYNA-N; [M+Hac-H]-; 3-cyano-2-butanone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.136; JFVBCXHSPKJLRP-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxopentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.062; SEYPSMUGVMMWTC-UHFFFAOYSA-N; [M+Hac-H]-; UNPD190150
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.062; WJTPWAHVZOSBBG-UHFFFAOYSA-N; [M+Hac-H]-; 2-hydroxypent-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FXXRPTKTLVHPAR-UHFFFAOYSA-N; [M-H]-; 1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VSVIYBLRPXAQBF-SNAWJCMRSA-N; [M-H]-; UNPD149056
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GZTZLYWUGFZVSM-UHFFFAOYSA-N; [M+Hac-H]-; UNPD103572
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; XJITTZAUZHVBLF-UHFFFAOYSA-N; [M+Hac-H]-; UNPD10382
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.283; DDRPCXLAQZKBJP-UHFFFAOYSA-N; [M+Hac-H]-; furan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; FXXRPTKTLVHPAR-UHFFFAOYSA-N; [M-H]-; 1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.958; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M-H]-; 5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.630; PBCLOVRWBLGJQA-UHFFFAOYSA-N; [M+Hac-H]-; 3-hydroxypent-4-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.593; GNMSLDIYJOSUSW-LURJTMIESA-N; [M-H]-; (2S)-1-acetylpyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.079; WRUSVQOKJIDBLP-HWKANZROSA-N; [M-H]-; 2-[[(E)-2-methylbut-2-enoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.071; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M-H]-; 2-(3-methylbut-2-enoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.041; FICAQKBMCKEFDI-UHFFFAOYSA-N; [M+Hac-H]-; 3,5-dimethyl-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M-H]-; 3-ethyl-5,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.724; ZPOODPZCZLCUAN-UHFFFAOYSA-N; [M+Hac-H]-; 3,4-dihydro-1H-pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.578; YVORRVFKHZLJGZ-UHFFFAOYSA-N; [M+Hac-H]-; 4,5-dimethyl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.521; ZCQGVFNHUATAJY-UHFFFAOYSA-N; [M-H]-; methyl 2-[methyl(prop-2-enoyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.458; PSOZJOZKEVZLKZ-UHFFFAOYSA-N; [M+Hac-H]-; 2,4-dimethyl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.380; NSAUQTCATRWAJC-UHFFFAOYSA-N; [M+Hac-H]-; 2,5-dimethyl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.319; QYJOOVQLTTVTJY-YFKPBYRVSA-N; [M-H]-; ethyl (2S)-5-oxopyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; ZEWHMWFASYXCAO-UHFFFAOYSA-N; [M+Hac-H]-; 4-ethenylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; MQXIMPGNIJCBHZ-UHFFFAOYSA-N; [M-H]-; 2-oxoazepane-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; OXRRHYRRQWIHIV-UHFFFAOYSA-N; [M+Hac-H]-; 2,3-dihydro-1H-pyridin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; YRXLABUVDQYDHV-UHFFFAOYSA-N; [M-H]-; 4-(prop-2-enoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; QTNLDKHXFVSKCF-UHFFFAOYSA-N; [M-H]-; 2-acetamidopent-4-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; NQAYDNHKIKCYNL-UHFFFAOYSA-N; [M-H]-; 2-[ethyl(prop-2-enoyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; PBVFADSFYQFKNL-UHFFFAOYSA-N; [M-H]-; [3-(methylamino)-3-oxopropyl] prop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; PNOKUGWGMLEAPE-UHFFFAOYSA-N; [M-H]-; 2-amino-2-(5-methyl-2,5-dihydrofuran-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; VNKGGLJCICOLTE-UHFFFAOYSA-N; [M+Hac-H]-; 4-isocyanatobut-1-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; BOEBLZSBALIVQU-UHFFFAOYSA-N; [M+Hac-H]-; 3-isocyanatobut-1-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; BKGPMRISIFTLAH-UHFFFAOYSA-N; [M-H]-; 3-[methyl(prop-2-enoyl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; FEFAOCZERLVSIS-UHFFFAOYSA-N; [M+Hac-H]-; 3-methylidenepyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; RJGVYIKJSMBGDK-UHFFFAOYSA-N; [M-H]-; 2-(3-ethyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; JFZRRXGXEHUJCI-UHFFFAOYSA-N; [M-H]-; methyl 1-methyl-5-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; FHHMWJMUMOYGQW-UHFFFAOYSA-N; [M-H]-; ethyl 2-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; JFVBCXHSPKJLRP-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxopentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; KHLMVJUFZYQPEP-IMJSIDKUSA-N; [M+Hac-H]-; (1S,5R)-3-azabicyclo[3.1.0]hexan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; VCBNATUBBVFIIW-UHFFFAOYSA-N; [M+Hac-H]-; 2-azabicyclo[2.1.1]hexan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; KORIJXKQGMTQTO-UHFFFAOYSA-N; [M+Hac-H]-; 1H-pyrrol-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; XBNGBGYWMXBQRX-UHFFFAOYSA-N; [M-H]-; methyl 4-oxopiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; BZOZZHITPNLXLM-UHFFFAOYSA-N; [M-H]-; 3-ethyl-2-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; PLYNVXKJUKCUOF-UHFFFAOYSA-N; [M+Hac-H]-; 2,3-dihydro-1H-pyridin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; SUCDHPJUXCCMDN-UHFFFAOYSA-N; [M+Hac-H]-; 2-ethyl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; IBJRDBSWQMNJKY-MOJAZDJTSA-N; [M-H]-; (1R,2S,3R,4S)-3-amino-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; DQYGBMLEVQLDQC-UHFFFAOYSA-N; [M-H]-; ethyl 3-oxopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; AGWPBFFUIGQGJG-UHFFFAOYSA-N; [M-H]-; 1-ethyl-5-oxopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; LTUABJAYJRTHEH-UHFFFAOYSA-N; [M+Hac-H]-; 3-ethyl-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; BNPUQHZYYWBHSW-UHFFFAOYSA-N; [M-H]-; 1-ethyl-5-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; LKIDEIDZBYIDNU-FSPLSTOPSA-N; [M-H]-; (3aS,6aR)-2,3,4,5,6,6a-hexahydrofuro[2,3-c]pyrrole-3a-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; QSEXRJPSOUALOF-UHFFFAOYSA-N; [M-H]-; 2-[cyclopropanecarbonyl(methyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M-H]-; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; IMAKOYSQAGRALB-UHFFFAOYSA-N; [M-H]-; 1,4-dioxa-8-azaspiro[4.5]decan-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; ROSIVTQTEZPZLA-UHFFFAOYSA-N; [M-H]-; 5-ethyl-5-methyl-1,3-oxazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M-H]-; methyl 2-(2-oxopyrrolidin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.856; XOMYTIUVNSWEAI-UHFFFAOYSA-N; [M-H]-; 3-(2-oxopyrrolidin-1-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.853; KNEPBZMJMJUNQX-UHFFFAOYSA-N; [M+Hac-H]-; pent-4-ynamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M-H]-; methyl (2S)-1-methyl-5-oxopyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; MKSLXHNNHFTOEE-UHFFFAOYSA-N; [M-H]-; 3,3a,4,5,6,6a-hexahydro-2H-furo[3,2-b]pyrrole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; ZHFYGKPIJJBFJH-UHFFFAOYSA-N; [M-H]-; 3-methyl-2-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.844; UHRUAPNWENGYTC-UHFFFAOYSA-N; [M-H]-; 2-nitrocycloheptan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; GVOZDJDCDYBBAW-UHFFFAOYSA-N; [M-H]-; 1,8-dioxa-3-azaspiro[4.5]decan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; PKCIDMQPMJHMGR-UHFFFAOYSA-N; [M-H]-; 7-oxoazepane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; LOQFROBMBSKWQY-ZCFIWIBFSA-N; [M-H]-; ethyl (3R)-4-cyano-3-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; XNABHFLZYMCJHE-UHFFFAOYSA-N; [M+Hac-H]-; furan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; LYNLJRWPCQRLBT-UHFFFAOYSA-N; [M-H]-; 1-carbamoylcyclopentane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; FMRUUBKNZCITHU-UHFFFAOYSA-N; [M-H]-; 1-(methylcarbamoyl)cyclobutane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; AJTPFZSLRYHOCT-UHFFFAOYSA-N; [M-H]-; ethyl 2-acetamidoprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; IZNTWTMLHCGAJU-UHFFFAOYSA-N; [M-H]-; 1-formylpiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; RZZIKHSWRWWPAN-UHFFFAOYSA-N; [M+Hac-H]-; oxolane-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.821; LKYYGCNRZKZWLZ-UHFFFAOYSA-N; [M-H]-; 2-(2-oxopiperidin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; FEQQMBBBBFVNMN-UHFFFAOYSA-N; [M-H]-; 1-acetylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; BIESXMIFDWYKTQ-UHFFFAOYSA-N; [M-H]-; methyl 2-oxopiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; FQRTVGXATBBMPJ-UHFFFAOYSA-N; [M-H]-; 1-methyl-2-oxopiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; GGOQYHOZFCWTNM-UHFFFAOYSA-N; [M+Hac-H]-; N-prop-2-ynylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; QXAZQNAFKUKXOL-UHFFFAOYSA-N; [M-H]-; ethyl 4-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; OBFVZDIXAGVZLZ-UHFFFAOYSA-N; [M-H]-; 7-oxoazepane-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; JDNLIMWIEMRHRE-UHFFFAOYSA-N; [M-H]-; 3-ethyl-3-(hydroxymethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; OSJXVCZDOUIGLI-UHFFFAOYSA-N; [M-H]-; 4-amino-2-oxabicyclo[3.1.1]heptane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; GRXPBUORVABFNC-XAHCXIQSSA-N; [M-H]-; (1R,4S,6R)-6-amino-2-oxabicyclo[2.2.1]heptane-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; QJYQNYXPOPJYSU-UHFFFAOYSA-N; [M-H]-; 2-(2-oxopiperidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; AAMWBMZCAOJKJU-UHFFFAOYSA-N; [M-H]-; 1-methyl-2-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; LGABVVFSYBSLDO-UHFFFAOYSA-N; [M-H]-; methyl 3-methyl-2-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; BSWMFLPHDUMFNS-UHFFFAOYSA-N; [M-H]-; 2-(1-methyl-2-oxopyrrolidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; WRWMSKHCARNZRC-UHFFFAOYSA-N; [M-H]-; 1,3-dimethyl-2-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.794; KZMBWDGCFLVNTQ-UHFFFAOYSA-N; [M-H]-; 1-(3-hydroxypropyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; UKQLYCSMIVXPDB-UHFFFAOYSA-N; [M-H]-; methyl 6-oxopiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; UMCLCZMPTREESK-UHFFFAOYSA-N; [M-H]-; 2-ethoxyethyl 2-cyanoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; LZBWETNXIZOALQ-UHFFFAOYSA-N; [M-H]-; methyl 5-methoxy-3,4-dihydro-2H-pyrrole-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.788; FMLCUICPLLRLEU-UHFFFAOYSA-N; [M-H]-; 1-methyl-6-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; YORUFIOEZHJAEZ-UHFFFAOYSA-N; [M-H]-; methyl 6-oxopiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; QSTXMZUAMCBUQU-UHFFFAOYSA-N; [M-H]-; 2-(1-methyl-5-oxopyrrolidin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; GTXXDFUYEKXHRF-UHFFFAOYSA-N; [M-H]-; 1-methyl-6-oxopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; JLIAUXQHFQGOGT-UHFFFAOYSA-N; [M-H]-; 2-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; PUGDEACANJGZAI-UHFFFAOYSA-N; [M-H]-; 1-(dimethylcarbamoyl)cyclopropane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; ZPCFPPPPCGXLQV-UHFFFAOYSA-N; [M-H]-; 3-methyl-6-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; GQAFTUMTSHDPRD-UHFFFAOYSA-N; [M-H]-; 2-(6-oxopiperidin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; SBYCWQPNKUMQSR-UHFFFAOYSA-N; [M-H]-; 2-(1-acetamidocyclopropyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; WWBAHELRZNIKDI-UHFFFAOYSA-N; [M-H]-; 2-(6-oxopiperidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; OZWUPGBEUVJVEN-RFZPGFLSSA-N; [M-H]-; (2R,4R)-4-methyl-6-oxopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; PNEZKQYBGLVCTO-UHFFFAOYSA-N; [M-H]-; 4-(oxolan-3-yl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; SYYWGSGPWFJYEG-UHFFFAOYSA-N; [M-H]-; 5-oxa-2-azaspiro[3.4]octane-7-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.776; RMZSOGJUEUFCBK-UHFFFAOYSA-N; [M-H]-; butyl 2-isocyanatoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; ORQZJANKFKDAHL-UHFFFAOYSA-N; [M-H]-; 2-(2-isocyanatoethyl)-2-methyl-1,3-dioxolane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; RTMKITWWTCEMNZ-UHFFFAOYSA-N; [M-H]-; methyl 2-oxa-5-azabicyclo[2.2.1]heptane-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.743; OANDNNNKGULGJK-UHFFFAOYSA-N; [M+Hac-H]-; oxolane-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.740; HUPVIAINOSTNBJ-HWKANZROSA-N; [M+Hac-H]-; (E)-3-ethoxyprop-2-enenitrile
COMMENT: CONFIDENCE Level 5: Exact mass of interest 156.066697; Observed in MS1; Charge state -1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.572
MS$FOCUSED_ION: PRECURSOR_M/Z 156.066697
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-2900000000-c3b04fa503ef4ab70a22
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  59.0135569 177.2361 ? 59.013536 10.9297 80.58 -0.1516 12
  88.0068933 197.7095 ? 88.006843 7.4653 56.05 0.7957 9
  89.0136199 274.9105 ? 89.013570 6.5833 161.14 0.5369 11
  103.0296302 247.1839 ? 103.029583 6.8912 68.87 1.0000 12
  129.0327601 999.0000 ? 129.032727 5.4870 27.39 0.8441 12
  129.0548170 625.5128 ? 129.054784 8.0896 128.08 0.5649 11
  130.0410110 759.1241 ? 130.040978 8.2743 160.84 0.7235 12
  161.0240770 156.5934 ? 161.024074 11.8802 64.12 0.0914 12
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  59.013557 177.24 177
  88.006893 197.71 197
  89.013620 274.91 274
  103.029630 247.18 247
  129.032760 999.00 999
  129.054817 625.51 625
  130.041011 759.12 759
  161.024077 156.59 156
//
